Victory Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-7,016
| Closed | -$264K | – | 2856 |
|
2021
Q1 | $264K | Sell |
7,016
-835,415
| -99% | -$31.4M | ﹤0.01% | 2446 |
|
2020
Q4 | $14.3M | Buy |
+842,431
| New | +$14.3M | 0.02% | 1009 |
|
2020
Q2 | – | Sell |
-11,852
| Closed | -$26K | – | 3637 |
|
2020
Q1 | $26K | Buy |
+11,852
| New | +$26K | ﹤0.01% | 3024 |
|
2019
Q4 | – | Sell |
-5,390
| Closed | -$21K | – | 3604 |
|
2019
Q3 | $21K | Buy |
+5,390
| New | +$21K | ﹤0.01% | 3033 |
|
2018
Q3 | – | Sell |
-1,102,760
| Closed | -$17.4M | – | 1928 |
|
2018
Q2 | $17.4M | Buy |
1,102,760
+35,670
| +3% | +$564K | 0.04% | 634 |
|
2018
Q1 | $18.3M | Buy |
1,067,090
+142,900
| +15% | +$2.45M | 0.04% | 605 |
|
2017
Q4 | $20.3M | Buy |
924,190
+391,550
| +74% | +$8.58M | 0.04% | 576 |
|
2017
Q3 | $21.8M | Sell |
532,640
-133,800
| -20% | -$5.47M | 0.05% | 557 |
|
2017
Q2 | $20.1M | Buy |
666,440
+149,340
| +29% | +$4.5M | 0.05% | 575 |
|
2017
Q1 | $18.7M | Buy |
517,100
+41,717
| +9% | +$1.51M | 0.04% | 597 |
|
2016
Q4 | $23.8M | Sell |
475,383
-113,350
| -19% | -$5.68M | 0.06% | 523 |
|
2016
Q3 | $30.9M | Buy |
+588,733
| New | +$30.9M | 0.09% | 405 |
|